AKT1 and prostate cancer: Similarly, both PC3 and DU145 cells were able to transmigrate through ShAkt1 HLEC monolayer than a shControl HLEC monolayer (Fig. 1c–e), thus indicating that endothelial Akt1 loss augments prostate cancer cell transendothelial migration.